Pipex Pharmaceuticals – Oral Flupirtine Opens IND With FDA for

by General Manager on 10th March 2008

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News

Pipex Pharmaceuticals’ Oral Flupirtine Opens IND With FDA for
CNNMoney.com
Fibromyalgia affects an estimated 6 million people in the US and recently Pfizer’s Lyrica® became the first FDA-approved treatment for fibromyalgia.

 

Leave a Comment

Previous post: Fralex reaches 100th patient milestone in fibromyalgia study

Next post: NEW: Acupuncture For Chronic Fatigue Syndrome – Jacinta’s experiences